tiprankstipranks
Advertisement
Advertisement
MaxCyte sees FY26 revenue $30M-$32M, consensus $38.41M
PremiumThe FlyMaxCyte sees FY26 revenue $30M-$32M, consensus $38.41M
3d ago
MaxCyte reports Q4 EPS (9c), consensus (8c)
Premium
The Fly
MaxCyte reports Q4 EPS (9c), consensus (8c)
3d ago
MaxCyte appoints Parmeet Ahuja as CFO
Premium
The Fly
MaxCyte appoints Parmeet Ahuja as CFO
5d ago
MaxCyte CFO Douglas Swirsky to transition out of role
PremiumThe FlyMaxCyte CFO Douglas Swirsky to transition out of role
5M ago
MaxCyte reiterates FY25 revenue guidance flat to down 10% vs. last year
Premium
The Fly
MaxCyte reiterates FY25 revenue guidance flat to down 10% vs. last year
5M ago
MaxCyte reports Q3 EPS (12c), consensus (9c)
Premium
The Fly
MaxCyte reports Q3 EPS (12c), consensus (9c)
5M ago
MaxCyte Announces Major Workforce Reduction Plan
PremiumCompany AnnouncementsMaxCyte Announces Major Workforce Reduction Plan
6M ago
MaxCyte Chief Commercial Officer Departs Amid Severance Agreement
Premium
Company Announcements
MaxCyte Chief Commercial Officer Departs Amid Severance Agreement
8M ago
MaxCyte downgraded to Neutral from Buy at BTIG
Premium
The Fly
MaxCyte downgraded to Neutral from Buy at BTIG
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100